Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 256 AL 270

[Therapy of psycho-behavioral disorders in the elderly]

Gallarda T.

Encephale. 2011 Sep;37(4 Suppl 4):H26-8. doi: 10.1016/S0013-7006(11)70031-8.

Memantine in everyday clinical practice: a comparison of studies in Germany and Greece

Förstl H, Stamouli SS, Janetzky W, Galanopoulos A, Karageorgiou C, Tzanakaki M.

Dement Geriatr Cogn Disord. 2011;32(4):267-72. doi: 10.1159/000334991. Epub 2012 Jan 9.

[New conception of Alzheimer's disease and the strategy for preclinical therapy]

Miyagawa T, Iwata A.

Nihon Rinsho. 2011 Dec;69 Suppl 10 Pt 2:252-6.

Staged decline of visual processing capacity in mild cognitive impairment and Alzheimer's disease

Bublak P, Redel P, Sorg C, Kurz A, Förstl H, Müller HJ, Schneider WX, Finke K.

Neurobiol Aging. 2011 Jul;32(7):1219-30. doi: 10.1016/j.neurobiolaging.2009.07.012. Epub 2009 Aug 26.

Potential predictors of hippocampal atrophy in Alzheimer's disease

Dhikav V, Anand K.

Drugs Aging. 2011 Jan 1;28(1):1-11. doi: 10.2165/11586390-000000000-00000.

Scientific truth or false hope? Understanding Alzheimer's disease from an aging perspective

Chen M, Maleski JJ, Sawmiller DR.

J Alzheimers Dis. 2011;24(1):3-10. doi: 10.3233/JAD-2010-101638.

Inflammation and oxidative damage in Alzheimer's disease: friend or foe?

Galimberti D, Scarpini E.

Front Biosci (Schol Ed). 2011 Jan 1;3(1):252-66. doi: 10.2741/s149.

Alzheimer's disease and age-related memory decline (preclinical)

Terry AV Jr, Callahan PM, Hall B, Webster SJ.

Pharmacol Biochem Behav. 2011 Aug;99(2):190-210. doi: 10.1016/j.pbb.2011.02.002. Epub 2011 Feb 24.

Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model

Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, Du Y, Doody RS, Le W.

J Alzheimers Dis. 2011;24(4):739-49. doi: 10.3233/JAD-2011-101875.

A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease

Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C.

Dement Geriatr Cogn Disord. 2011;31(2):158-64. doi: 10.1159/000324438. Epub 2011 Feb 19.

Inflammatory risk factors and pathologies associated with Alzheimer's disease

Sastre M, Richardson JC, Gentleman SM, Brooks DJ.

Curr Alzheimer Res. 2011 Mar;8(2):132-41. doi: 10.2174/156720511795256062.

Sublingual sufentanil for incident pain and dementia-related response agitation

Passmore MJ.

Int Psychogeriatr. 2011 Jun;23(5):844-6. doi: 10.1017/S1041610211000275. Epub 2011 Feb 25.

Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease

Rissman RA, Mobley WC.

J Neurochem. 2011 May;117(4):613-22. doi: 10.1111/j.1471-4159.2011.07237.x. Epub 2011 Mar 28.

[Early onset Alzheimer's disease - diagnosis, therapy and management]

Natale B, Wohlrab D, Förtsch B, Kurz A, Diehl-Schmid J.

Fortschr Neurol Psychiatr. 2011 Mar;79(3):144-51. doi: 10.1055/s-0029-1245811. Epub 2011 Mar 10.

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease

Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L.

Dement Geriatr Cogn Disord. 2011;31(3):218-24. doi: 10.1159/000326213. Epub 2011 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias